A venous leg ulcer (VLU) is defined as the loss of skin below the knee on the leg or foot in the presence of venous disease. These ulcers persist for more than 6 weeks and are therefore referred to as chronic venous leg ulcers, representing the most advanced form of chronic venous disorders like varicose veins and lipodermatosclerosis.
Risk factors for Venous Leg Ulcer include older age, obesity, trauma, immobility, congenital absence of veins, deep vein thrombosis (DVT), phlebitis, and factor V Leiden mutation. The cornerstone of the diagnosis of chronic venous insufficiency includes demonstrating venous disease. The clinician must rule out the significant coexisting arterial disease by performing a thorough clinical assessment and obtaining an ankle-brachial pressure index.
Venous Leg Ulcer has a negative impact on the quality of life and results in considerable costs to both patients and healthcare providers. Also, there are no uniform guidelines for the assessment and management of this group of conditions, which is reaching epidemic proportions in prevalence.
Get FREE sample copy at:
The Venous Leg Ulcer market report also covers emerging drugs, current treatment practices, Venous Leg Ulcer market share of the individual therapies, current and forecasted Venous Leg Ulcer Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Venous Leg Ulcer treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Venous Leg Ulcer Market Key Facts
Among 7MM, the United States accounted for the highest market size of venous leg ulcers in comparison to EU5 and Japan in 2017.
Venous ulcers (VUs) account for approximately 75% of all chronic leg ulcers and are characterized by several factors that hinder and delay healing. According to a study by Nelson et al. (n.d.) between 1.5/1,000 and 3.0/1.000 people have active leg ulcers and prevalence increases with age to about 20/1,000 people aged over 80 years.
Venous leg ulceration occurs secondary to venous reflux or obstruction. It affects up to 3 in 1,000 people (Nelson et al.).
Leg ulcers are usually secondary to venous reflux or obstruction, but 20% of persons with leg ulcers have arterial disease, with or without venous disorders.
According to the NHS, venous leg ulcer is the most common type of leg ulcer, accounting for more than 90% of all cases.
Key Benefits of Venous Leg Ulcer Market Report
Venous Leg Ulcer market report provides an in-depth analysis of Venous Leg Ulcer Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
The Venous Leg Ulcer market report will help in developing business strategies by understanding the Venous Leg Ulcer Market trends & developments, key players, and future market competition that will shape and drive the Venous Leg Ulcer market in the upcoming years.
The Venous Leg Ulcer market report covers Venous Leg Ulcer’s current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Venous Leg Ulcer market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Venous Leg Ulcer Market
The Venous Leg Ulcer market size is expected to increase during the forecast period. The increase in market size is a direct consequence of the increasing number of patients suffering from Venous Leg Ulcer in the 7MM, which would lead to higher adoption of therapeutic drugs in the forecasted period.
The Venous Leg Ulcer market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Venous Leg Ulcer market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Venous Leg Ulcer market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Venous Leg Ulcer Epidemiology
The Venous Leg Ulcer epidemiology section covers insights about the historical and current Venous Leg Ulcer patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Venous Leg Ulcer Drugs Uptake and Key Market Players
The Venous Leg Ulcer Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Venous Leg Ulcer market or expected to get launched in the market during the study period. The analysis covers Venous Leg Ulcer market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Venous Leg Ulcer Companies
And many others.
Venous Leg Ulcer therapies covered in the report include:
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Venous Leg Ulcer Competitive Intelligence Analysis
4. Venous Leg Ulcer Market Overview at a Glance
5. Venous Leg Ulcer Disease Background and Overview
6. Venous Leg Ulcer Patient Journey
7. Venous Leg Ulcer Epidemiology and Patient Population
8. Venous Leg Ulcer Treatment Algorithm, Current Treatment, and Medical Practices
9. Venous Leg Ulcer Unmet Needs
10. Key Endpoints of Venous Leg Ulcer Treatment
11. Venous Leg Ulcer Marketed Products
12. Venous Leg Ulcer Emerging Therapies
13. Venous Leg Ulcer Seven Major Market Analysis
14. Attribute Analysis
15. Venous Leg Ulcer Market Outlook (7 major markets)
16. Venous Leg Ulcer Access and Reimbursement Overview
17. KOL Views on the Venous Leg Ulcer Market.
18. Venous Leg Ulcer Market Drivers
19. Venous Leg Ulcer Market Barriers
21. DelveInsight Capabilities
Venous Leg Ulcers Pipeline Insights
Venous Leg Ulcers Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Venous Leg Ulcers market.
Latest BioPharma Blog
Chronic Refractory Cough Treatment Market
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd. 2432
City: Las Vegas
Country: United States